Sheridan/CF Novaplus 7.0 mm, REF V5-10114 Product Usage: Tracheal tube/airway management

FDA Device Recall #Z-2317-2019 — Class I — July 30, 2019

Recall Summary

Recall Number Z-2317-2019
Classification Class I — Serious risk
Date Initiated July 30, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Teleflex Medical
Location Morrisville, NC
Product Type Devices
Quantity 77136 units

Product Description

Sheridan/CF Novaplus 7.0 mm, REF V5-10114 Product Usage: Tracheal tube/airway management

Reason for Recall

Reported complaints indicate an increased incidence of specific lots of the 15 mm Sheridan connector becoming disconnected from the endotracheal tube (ETT). Disconnection from the breathing circuit may result in insufficient oxygenation, requiring medical intervention.

Distribution Pattern

US Nationwide Distribution

Lot / Code Information

Batch numbers: 73K1600156 73K1600735 73L1600501 73A1700120 73B1700321 73C1700425 73D1700630 73E1700504 73G1700146 73H1700053 73J1700307 73K1700085 73B1800223 73B1800371 73C1800372 73D1800655 73E1800579 73G1800627 73H1800203 73H1800429 73H1800758 73J1800118 73J1800696

Other Recalls from Teleflex Medical

Recall # Classification Product Date
Z-0703-2020 Class II HUDSON RCI SHERIDAN SHERI-BRONCH Endobronchial ... Oct 30, 2019
Z-0688-2020 Class II Arrow EZ-IO Intraosseous Vascular Access System... Oct 8, 2019
Z-0689-2020 Class II Arrow EZ-IO Intraosseous Vascular Access System... Oct 8, 2019
Z-0690-2020 Class II Arrow EZ-IO Intraosseous Vascular Access System... Oct 8, 2019
Z-0496-2020 Class II WECK AutoEndo5, Automatic Hem-O-Lok Clip Applie... Oct 4, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.